There is a lot of volatility in the receipts and I just can't tell to what extent FY17Q1 was a one-off. To quote their September 2015 4C: "The Board and Management are very pleased with the positive momentum building in each of its core business segments". This same momentum saw FY16Q2 receipts decrease from $6.6m to $5.1m; during FY16H2, FY16Q3 had higher receipts and FY16Q4 had lower receipts. So you may appreciate why I don't automatically take "This stronger result [FY17Q1] is anticipated to continue into Q2FY17" as an indication that revenues and earnings are about to fly. For all I know, FY17Q2 receipts could be $2m to $3m lower than $9.6m and they could be cashflow negative. I've just interpreted the latest quarter with more conservatism than you, so I'm less optimistic. I need another quarter of solid receipts and net operating cash flow, before I'm willing to call this a buy.
Sep-15 Dec-15 Mar-16 Jun-16 Sep-16 1 Receipts 6,556 5,076 7,169 6,053 9,562 2 NOCF (184) (503) 1,908 (1,289) 527
- Forums
- ASX - By Stock
- SEQ
- Ann: Change of Director's Interest Notice
SEQ
sequoia financial group ltd
Add to My Watchlist
1.43%
!
35.5¢

Ann: Change of Director's Interest Notice, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $43.87M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 35.0¢ | $37.20K | 105.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 56039 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 19052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50325 | 0.350 |
1 | 2944 | 0.340 |
1 | 2982 | 0.335 |
1 | 3000 | 0.330 |
2 | 69535 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 19052 | 2 |
0.360 | 134902 | 2 |
0.365 | 72540 | 3 |
0.370 | 33513 | 2 |
0.375 | 89000 | 3 |
Last trade - 15.00pm 27/06/2025 (20 minute delay) ? |
Featured News
SEQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online